Dymicron Revenue and Competitors
Estimated Revenue & Valuation
- Dymicron's estimated annual revenue is currently $9.8M per year.
- Dymicron's estimated revenue per employee is $251,000
Employee Data
- Dymicron has 39 Employees.
- Dymicron grew their employee count by -2% last year.
Dymicron's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP, Corporate Development and Chief Strategy Officer | Reveal Email/Phone |
2 | VP, Research & Development | Reveal Email/Phone |
3 | Regulatory Affairs Officer | Reveal Email/Phone |
4 | SVP, Commercial Operations | Reveal Email/Phone |
5 | Production Manager | Reveal Email/Phone |
6 | Manufacturing Manager | Reveal Email/Phone |
7 | Machinist | Reveal Email/Phone |
8 | Quality Engineer/ Management Representative | Reveal Email/Phone |
9 | Team Member at Dymicron | Reveal Email/Phone |
10 | R&D Engineer | Reveal Email/Phone |
Dymicron Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $94.6M | 377 | 28% | N/A | N/A |
#2 | $16.8M | 67 | -17% | N/A | N/A |
#3 | $485.4M | 1934 | 7% | N/A | N/A |
#4 | $43.7M | 174 | 15% | N/A | N/A |
#5 | $75M | 192 | 43% | $12.8M | N/A |
#6 | $6M | 24 | -8% | N/A | N/A |
#7 | $7.3M | 29 | -22% | N/A | N/A |
#8 | $38.4M | 153 | 3% | N/A | N/A |
#9 | $174.4M | 695 | 9% | N/A | N/A |
#10 | $6.8M | 27 | -34% | N/A | N/A |
What Is Dymicron?
Dymicron is a privately held, innovative medical technology company that is advancing a new generation of musculoskeletal implant devices made from polycrystalline diamond (PCD) — one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use for all medical applications in the human body.
keywords:N/AN/A
Total Funding
39
Number of Employees
$9.8M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.3M | 39 | N/A | N/A |
#2 | $3.1M | 39 | -5% | N/A |
#3 | $4.7M | 39 | -5% | N/A |
#4 | $10.6M | 40 | 5% | N/A |
#5 | $8.6M | 40 | -11% | N/A |